Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs MacroGenics, Inc. (MGNX)

Inovio Pharmaceuticals, Inc. and MacroGenics, Inc. are both Biotechnology companies. MacroGenics, Inc. is the larger, with a market value of $148.4M against $125.6M — 1.2× the size. MacroGenics, Inc. grew revenue faster over the last twelve months: 1.32% against −54.8%. Inovio Pharmaceuticals, Inc. has the higher net margin (0.00% vs −8.70%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, MacroGenics, Inc. leads on 10 and Inovio Pharmaceuticals, Inc. on 6.

Valuation

Metric INO MGNX Biotechnology median
P/E n/m n/m 10.60
P/S 258.10 0.88 9.40
P/B 22.78 3.46 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.61 0.66
EV/Sales 206.11 (0.11) 9.02
Earnings yield (94.67%) (9.44%) (32.88%)
Free cash flow yield (80.41%) (44.23%) (23.13%)

Profitability

Metric INO MGNX Biotechnology median
Gross margin 100.00% 85.23% 68.51%
Operating margin 0.00% (20.45%) 0.00%
Net margin 0.00% (8.70%) 0.00%
Free cash flow margin 0.00% (39.08%) 0.00%
Return on equity (409.87%) (32.61%) (51.96%)
Return on assets (114.64%) (4.94%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO MGNX Biotechnology median
Revenue growth (TTM) (54.82%) 1.32% 6.76%
EPS growth (last fiscal year) 54.18% (10.28%) 29.88%
Revenue growth, 5-year CAGR (61.18%) 7.35% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO MGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 2.96 4.97
Net debt to EBITDA 0.70 2.82 1.01

Dividend

Metric INO MGNX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO MGNX Biotechnology median
Market cap 125.63m 148.42m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack